Analysis of the key themes driving private equity deal activity reveals that robotics accounted for 2 medical devices deals announced in Q2 2023, worth a total value of $28m. The $23m investment by Cigna Ventures, Hikma Ventures, Hunt Holdings, LabCorp Venture Fund, Marshall Wace, Maywic Select Investments, Merck Global Health Innovation Fund, Red and Blue Ventures and Safeguard Scientifics in Prognos Health was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q2 2023 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
Smarter leaders trust GlobalData
In value terms, robotics-related deal activity decreased by % in Q2 2023 compared with the previous quarter’s total of . Related deal volume remained flat in Q2 2023 versus the previous quarter.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q2 2023 – Thematic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Buyouts and Direct Investments done by Private Equity firms.
